Obesity Clinical Trial
Official title:
A Pilot Study of an eHealth-delivered Health Coaching Intervention
NCT number | NCT03309787 |
Other study ID # | D17123 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 29, 2017 |
Est. completion date | December 1, 2019 |
Verified date | July 2020 |
Source | Dartmouth-Hitchcock Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The national epidemic of obesity is associated with considerable morbidity, disability and
early mortality.
Conventional weight loss programs beyond a primary care setting have the potential to reduce
weight, but are difficult to access for adults with obesity in rural areas due to lack of
transportation and access to specialty care. Routine intensive behavioral therapy, while
effective, is often not supplemented with adjuncts that could be helpful in engaging
participants in behavioral change. The overarching goal of this SYNERGY pilot project is to
overcome barriers rural adults face by using video-conferencing to deliver specialty obesity
care that otherwise is inaccessible to most adults faced with this disease. It also intends
to use emerging mobile health (mHealth) technology which has shown considerable promise in
providing motivational feedback. This proposal highlights T3/T4 translation bridging
technologists, allied health staff, and clinicians in the development and implementation of
new therapeutic modalities. The study aims to evaluate a telehealth-based health coaching
program that is embedded in the Dartmouth-Hitchcock Weight and Wellness Center that
integrates novel remote monitoring technology in effecting behavioral change using Amulet, a
Dartmouth Computer Science developed mHealth device over a 16-week period. First, the
feasibility and accessibility of an eHealth-delivered health coaching obesity intervention
using remote monitoring and video-conferencing (Aim 1) will be evaluated. The potential
effectiveness of achieving the primary outcome of 5% weight loss, with secondary outcomes of
improved physical function and self reported health (Aim 2) will be ascertained. The
intervention's impact on implementation outcomes of workflow, adoption, and organizational
change that could affect further scalability and generalizability in other high-risk
population groups (Aim 3) will be assessed. These preliminary findings will be used in a
future competitive application for an extramural R01 designed to assess the effectiveness of
our intervention in achieving weight loss in rural obese adults. If successful, this
application has the potential to redesign care using applied methods of telehealth translated
to community-based, rural populations to facilitate behavioral change. The project also meets
criteria of the NIH Strategic Plan for Obesity and the Institute of Medicine's need for
Telehealth research.
Status | Completed |
Enrollment | 37 |
Est. completion date | December 1, 2019 |
Est. primary completion date | October 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - English speaking; - Community-dwelling; - Age 18-65 years; - Obesity based on: BMI =30kg/m2 54; - Participating in the DH-WWC health coach program; - Access to home, high-speed internet with Wi-Fi; - Medical clearance from their primary care provider; - Provide voluntary, written consent; - Require an EHR patient portal account and credentials ; -----If subjects do not have an account, one will be created for the purposes of this study Exclusion Criteria: - Unwilling to participate in the 16 week pilot or complete study measures; - Individuals unwilling/unable to provide consent; - A medical record diagnosis of dementia as intensive behavioral therapy and health coaching require the ability to complete questionnaires and change behavior, all of which may be challenging in individuals with cognitive impairment; - Cognitive impairment measured by the 6-item Callahan screen, a brief and reliable six-item screening questionnaire with acceptable sensitivity (88.7%) and specificity (88.0%) in identifying individuals with cognitive impairment. Its diagnostic properties are comparable to the full Folstein Mini-Mental Status Examination in those scoring =3. This questionnaire can be administered by telephone or face-to-face interview and is being as an adjunct to medical record documentation of cognitive impairment; - Life-threatening illness including those receiving palliative care or hospice services; - Nursing facility or hospital admission in the past six months; - Psychiatric diagnosis that would interfere with study participation and require significant modification to meet their needs such as major depressive disorder, substance abuse, suicidal ideation or severe mental illness (schizophrenia, bipolar disorder); - History of bariatric surgery; - American College of Sports Medicine contraindications to exercise57 including: a resting heart rate of >120bpm; Blood pressure >180/100mmHg; unstable angina; |
Country | Name | City | State |
---|---|---|---|
United States | Dartmouth-Hitchcock | Lebanon | New Hampshire |
Lead Sponsor | Collaborator |
---|---|
Dartmouth-Hitchcock Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Staff Adoption | Staff Adoption: Haug's 12-item Measure of Evidence-Based Practice Adoption assesses stage of change, experience, attitudes, organization barriers and strategies to support evidence-based practices (1-5 point scale - strongly disagree to agree). | 16 weeks | |
Primary | Completion Rate: Number of Participants Completing the Intervention | Completion/ Feasibility: The following rates will be computed: screened for inclusion; eligibility; enrollment; completion; assessment. We will assess entry criteria (reasons for dropout/non-adherence) and time to collect data. Enrollment success will be defined as 30 patients. Adequate retention is defined as a dropout rate of <20%. Completion of >80% of post-study measures will be defined as adequate. Attending >80% of sessions will be considered acceptable. Staff will track equipment, software or technical issues (malfunctions, data loss, hardware) in a journal. | 16 weeks | |
Primary | Acceptability | Acceptability: Qualitative interviews will ensure the appropriateness of the pilot and its strengths/weaknesses. Participants will answer questions on a scale from 0-5, where 5 = high acceptability of the program. | 16 Weeks | |
Secondary | Change in Weight | Weight will be measured using a Seca 770 analyzer (in clinic) and by the Omron HBF-514 (at home remotely). Weight Loss (change in weight) | Baseline/16 weeks | |
Secondary | Change in 6 Minute Walk | 6-Minute Walk (6MWT) is a cardiovascular fitness surrogate measuring distance (normal 400-700m) related to function. A clinically important difference or change is 50-55m | Baseline/16 weeks - pre/post change - increase = longer distance | |
Secondary | Diet Change | The Rapid Eating Assessment for Participants (REAPS) is a 16 item survey (score 13-39) of diet habits. Higher scores = higher diet quality. Positive score = better diet quality | Baseline/16 weeks | |
Secondary | Subjective Health | The 10-question, non-proprietary Patient Reported Outcomes Measurement Information Systems General Health-10 (PROMIS) captures physical, mental and social aspects of quality of life. Positive change scores = improved health. The score ranges from 0-100, 50 is the population mean, 10 consists of 1SD, and higher scores equate better health. | Baseline/16 weeks - Change | |
Secondary | Readiness to Change | The University of Rhode Island Change Assessment is a 12 item questionnaire assessing one's stages of change based on contemplation, action, maintenance and pre-contemplation.. The range of scores from -2 to +14. Higher scores indicate higher readiness to change | 16 weeks | |
Secondary | Willingness to Pay | Patient Perception of Value: Two questions will assess Willingness to Pay (WTP) - whether they would pay for telemedicine delivery of the intervention in lieu of in-person travel time or cost. | 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |